Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-001969
Filing Date
2025-03-17
Accepted
2025-03-17 16:38:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4992
  Complete submission text file 0001950047-25-001969.txt   6477
Mailing Address C/O CG ONCOLOGY, INC. 400 SPECTRUM DRIVE SUITE 2040 IRVINE CA 92618
Business Address
POST LEONARD E (Reporting) CIK: 0001235862 (see all company filings)

Type: 144

Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Subject) CIK: 0001991792 (see all company filings)

EIN.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41925 | Film No.: 25745121
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)